연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
2087. Androgen receptor inhibitor enhances the anti-tumor effect of PARP inhibitor in breast cancer cells by modulating DNA damage response
Ahrum Min, Hyemin Jang, Seongyeong Kim, Kyung-Hun Lee, Debora Keunyoung Kim, Koung Jin Suh, Yaewon Yang, Paul Elvin, Mark J. O`Connor, and Seock-Ah Im
Mol Cancer Ther. 2018 Dec;17(12):2507-2518
Link
2086. Fulvestrant plus goserelin versus anastrozole plus goserelin versus goserelin alone for hormone receptor-positive, HER2-negative tamoxifen-pretreated premenopausal women with recurrent or metastatic breast cancer (KCSG BR10-04): a multicentre,open-label, three-arm, randomised phase II trial (FLAGstudy)
Ji-Yeon Kim, Seock-Ah Im, Kyung Hae Jung, Jungsil Ro, Joohyuk Sohn, Jee Hyun Kim, Yeon Hee Park, Tae-Yong Kim, Sung-Bae Kim, Keun Seok Lee, Gun Min Kim, Se Hyun Kim, Seonwoo Kim, Jin Seok Ahn, Kyung-Hun Lee, Jin-Hee Ahn, In Hae Park, Young-Hyuck Im
Eur J Cancer. 2018 Nov;103:127-136
Link
2085. A phase II trial of the pan-HER inhibitor poziotinib, in patients with HER2-positive metastatic breast cancer who had received at least two prior HER2-directed regimens: results of the NOV120101-203 trial
Yeon Hee Park, Kyung-Hun Lee, Joo Hyuk Sohn, Keun Seok Lee, Kyung Hae Jung, Jee-Hyun Kim, Ki Hyeong Lee, Jin Seok Ahn, Tae-Yong Kim, Gun Min Kim, In Hae Park, Sung-Bae Kim, Se Hyun Kim, Hye Sook Han, Young-Hyuck Im, Jin-Hee Ahn, Jung-Yong Kim, Jahoon Kang, Seock-Ah Im
Int J Cancer. 2018 Dec 15;143(12):3240-3247
Link
2084. Pan-Pim Kinase Inhibitor AZD1208 Suppresses Tumor Growth and Synergistically Interacts with Akt Inhibition in Gastric Cancer Cells
Miso Lee, Kyung-Hun Lee, Ahrum Min, Jeongeun Kim, Seongyeong Kim, Hyemin Jang, Jee Min Lim, So Hyeon Kim, Dong-Hyeon Ha, Won Jae Jeong, Koung Jin Suh, Yae-Won Yang, Tae Yong Kim, Do-Youn Oh, Yung-Jue Bang, Seock-Ah Im
Cancer Res Treat. 2018 Jun 6. [Epub ahead of print]
Link
2083. Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells
Ahrum Min, Jung Eun Kim, Yu-Jin Kim, Jee Min Lim, Seongyeong Kim, Jin Won Kim, Kyung-Hun Lee, Tae-Yong Kim, Do-Youn Oh, Yung-Jue Bang, Seock-Ah Im
Cancer Lett.. 2018 Aug 28;430:123-132
Link
2082. Recent treatment patterns and survival outcomes in pancreatic cancer according to clinical stage based on single-center large-cohort data.
Lee DH1, Jang JY1, Kang JS1, Kim JR1, Han Y1, Kim E1, Kwon W1, Kim SW1.
J Hepatobiliary Pancreat Sci. 2018 Feb;25(2):124-130. doi: 10.1002/jhbp.520. Epub 2017 Dec 14.
Link
2081. Prognostic predictability of the new American Joint Committee on Cancer 8th staging system for distal bile duct cancer: limited usefulness compared with the 7th staging system.
Kang JS1, Lee S2, Son D2, Han Y1, Lee KB3, Kim JR1, Kwon W1, Kim SW1, Jang JY1.
J Hepatobiliary Pancreat Sci. 2018 Feb;25(2):131-141. doi: 10.1002/jhbp.521. Epub 2017 Dec 14.
Link
2080. Optimal extent of surgery for early gallbladder cancer with regard to long-term survival: a meta-analysis.
Lee H1, Kwon W1, Han Y1, Kim JR1, Kim SW1, Jang JY1.
J Hepatobiliary Pancreat Sci. 2018 Feb;25(2):131-141. doi: 10.1002/jhbp.521. Epub 2017 Dec 14.
Link
2079. Progression of Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasm Associates With Cyst Size.
Han Y1, Lee H1, Kang JS1, Kim JR1, Kim HS1, Lee JM2, Lee KB3, Kwon W1, Kim SW1, Jang JY4.
Gastroenterology. 2018 Feb;154(3):576-584. doi: 10.1053/j.gastro.2017.10.013. Epub 2017 Oct 23.
Link
2078. Preoperative biliary drainage adversely affects surgical outcomes in periampullary cancer: a retrospective and propensity score-matched analysis.
Lee H1, Han Y1, Kim JR1, Kwon W1, Kim SW1, Jang JY1.
J Hepatobiliary Pancreat Sci. 2018 Mar;25(3):206-213. doi: 10.1002/jhbp.529. Epub 2018 Jan 21.
Link